Clinical Evaluation of Pink Esthetic Score

Clinical evaluation of pink esthetic score in delayed implants in thin gingival biotype with and without temporization in the esthetic zone

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thin Gingiva

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cairo University

Cairo, Egypt

About this study

Clinical evaluation of the pink esthetic score with and withiut temporization in thin gingival biotype in the maxillary esthetic zone with subepithelial connective tissue graft in bith groups

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with missing teeth in the maxillary esthetic zone with thin gingival biotype and adequate arch space

Exclusion criteria

deficient ridge , crowns on the adjacent teeth

Treatment and study plan

Connective tissue graft and implant placement

Procedure

Augmenting soft tissue with connective tissue graft

Primary outcomes

Pink esthetic score

Time frame: 1 year from the base line

Clinical assessment accotding to furhausser et al

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Clinical Evaluation of Pink Esthetic Score Following Delayed Implant Placement With Connective Tissue Graft With and Without Temporization in the Maxillary Esthetic Zone With Thin Gingival Biotype

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Jan 3, 2019
Registry last updated: Oct 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed